News
ReNeuron's latest press releases
ReNeuron secures funding from Michael J. Fox Foundation for ReN004 stem cell therapy for Parkinson's disease. 24/01/07
Guildford, UK, 24 January 2007: ReNeuron Group plc (LSE: RENE) today announces that it has been awarded a grant from the US-based Michael J. Fox …
Read articleRegulatory Update. 12/01/07
Guildford, UK, 12 January 2007: ReNeuron Group plc (LSE: RENE) today provides a further update regarding its recently filed Investigational New Drug (…
Regulatory Update. 09/01/07
Guildford, UK, 9 January 2007: ReNeuron Group plc (LSE: RENE) today provides an update regarding its recently filed Investigational New Drug (IND) …
Results of exercise of warrants. 14/12/06
Guildford, UK, 14 December 2006: ReNeuron Group plc (LSE: RENE) today announces that the Company has raised approximately £1.9 million from the …
ReNeuron announces filing IND application to the FDA for ReN001. 06/12/06
ReNeuron files IND application to commence human clinical studies with ReN001 stem cell therapy for stroke First such application to use neural (…
ReNeuron and CellSeed announce collaboration using ReNcellTM liver cell lines. 30/11/06
Guildford, UK, 30 November 2006: ReNeuron Group plc (LSE: RENE.L) and CellSeed Inc., a privately owned tissue engineering company based in Tokyo, …
Interims: Notification of Interim Results. 23/11/06
Guildford, UK, 22 November 2006: ReNeuron Group plc (LSE: RENE.L) today announces that it will report its interim results for the six months ended 30 …
ReNeuron and Millipore announce market launch of ReNcellTMneural stem cell lines. 20/11/06
Guildford,UK, 20 November 2006: ReNeuron Group plc (LSE:RENE.L) and Millipore Corporation (NYSE:MIL), announce the market launch of ReNeuron's …
<< 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 >>If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.
Top of page